000 | 01903 a2200577 4500 | ||
---|---|---|---|
005 | 20250515021638.0 | ||
264 | 0 | _c20061024 | |
008 | 200610s 0 0 eng d | ||
022 | _a0026-895X | ||
024 | 7 |
_a10.1124/mol.105.021204 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMulligan, Jude M | |
245 | 0 | 0 |
_aIdentification of tubulin as the molecular target of proapoptotic pyrrolo-1,5-benzoxazepines. _h[electronic resource] |
260 |
_bMolecular pharmacology _cJul 2006 |
||
300 |
_a60-70 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xmetabolism |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 | _aBinding Sites |
650 | 0 | 4 | _aBinding, Competitive |
650 | 0 | 4 | _aBlotting, Western |
650 | 0 | 4 |
_aCDC2 Protein Kinase _xmetabolism |
650 | 0 | 4 |
_aCarbamates _xpharmacology |
650 | 0 | 4 | _aCell Division |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aColchicine _xmetabolism |
650 | 0 | 4 |
_aCyclin B _xmetabolism |
650 | 0 | 4 | _aCyclin B1 |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aG2 Phase |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aK562 Cells |
650 | 0 | 4 |
_aMetaphase _xdrug effects |
650 | 0 | 4 |
_aMicrotubules _xdrug effects |
650 | 0 | 4 |
_aOxazepines _xmetabolism |
650 | 0 | 4 |
_aPyrroles _xmetabolism |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aTubulin _xmetabolism |
650 | 0 | 4 |
_aVinblastine _xmetabolism |
700 | 1 | _aGreene, Lisa M | |
700 | 1 | _aCloonan, Suzanne | |
700 | 1 | _aMc Gee, Margaret M | |
700 | 1 | _aOnnis, Valeria | |
700 | 1 | _aCampiani, Giuseppe | |
700 | 1 | _aFattorusso, Caterina | |
700 | 1 | _aLawler, Mark | |
700 | 1 | _aWilliams, D Clive | |
700 | 1 | _aZisterer, Daniela M | |
773 | 0 |
_tMolecular pharmacology _gvol. 70 _gno. 1 _gp. 60-70 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1124/mol.105.021204 _zAvailable from publisher's website |
999 |
_c16178712 _d16178712 |